Search
Now showing items 1-1 of 1
Mortality Aacross two ART trials enrolling at ≤200 vs ≤350 CD4 cells uL in Kenya
(University of Nairobi, 2015-02-26)
Background: In 2011, Kenyan HIV treatment guidelines changed from initiating ART at a CD4 of ≤200 to ≤350 cells/uL. We compared 6-month mortality in 2 research cohorts, one
enrolled before and one after the 2011 ART ...